NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Illinois shed jobs for a second straight month at the end of 2025, the sharpest pullback since the post-pandemic rebound began, even as Chicago’s job market proved more resilient.Read More